Breast imaging firm TransScan Research and Development of Ramsey, NJ, landed a heavy hitter this month when it hired former Trex Medical chief executive Hal Kirshner as chairman. Kirshner will lead TransScan’s executive team as the company
Breast imaging firm TransScan Research and Development of Ramsey, NJ, landed a heavy hitter this month when it hired former Trex Medical chief executive Hal Kirshner as chairman. Kirshner will lead TransScans executive team as the company moves its T-Scan 2000 electrical impedance imaging system to market. T-Scan 2000 received premarket approval from the Food and Drug Administration last month (SCAN 4/28/99).
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.